Panel discussions include: how to assure clinical quality during and post-COVID, the shift to virtual trials, and how COVID-19 has impacted clinical risk management at companies with limited resources.
Featured Speakers
Federico Feldstein, J.D.
Vice President, Head of BioResearch Quality and Compliance JOHNSON & JOHNSON
Kathy Goin
Vice President, Development Operations PALVELLA THERAPEUTICS, INC.
David Fryrear
Senior Vice President, Head of Clinical & Research Quality Assurance ASTELLAS
Michele Weitz
Senior Director, Clinical Standards and Innovation CLOVIS ONCOLOGY
Not Interested in Receiving Further Email Promotion Regarding this Event? Click Here
Want to reach 137,000+ Fierce Biotech subscribers with your own message? Contact aalcover@questex.com or call 202-824-5074.
You are currently subscribed as newsletter@newslettercollector.com. If you no longer wish to receive communications from Fierce Biotech's trusted partners, simply click here to unsubscribe. Refer to our Privacy Policy.
Questex, LLC 685 3rd Avenue, 21st Floor New York, NY 10017
